CRIS Current Research Information System

CARELLA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.591
EU - Europa 1.161
NA - Nord America 1.091
SA - Sud America 95
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 79
OC - Oceania 6
Totale 4.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.049
IT - Italia 578
VN - Vietnam 454
SG - Singapore 398
CN - Cina 368
DE - Germania 119
SE - Svezia 112
HK - Hong Kong 102
NL - Olanda 84
BR - Brasile 70
KR - Corea 62
GB - Regno Unito 56
BD - Bangladesh 55
IN - India 53
FR - Francia 44
FI - Finlandia 43
RU - Federazione Russa 39
IE - Irlanda 26
JP - Giappone 26
CA - Canada 20
CI - Costa d'Avorio 20
AR - Argentina 14
JO - Giordania 14
NG - Nigeria 14
TG - Togo 14
MX - Messico 12
PL - Polonia 12
TH - Thailandia 12
AT - Austria 10
ID - Indonesia 10
SC - Seychelles 10
ZA - Sudafrica 10
BE - Belgio 8
ES - Italia 7
IQ - Iraq 7
AU - Australia 6
PH - Filippine 6
LT - Lituania 5
SA - Arabia Saudita 5
TW - Taiwan 5
MY - Malesia 4
PY - Paraguay 4
RS - Serbia 4
EC - Ecuador 3
SV - El Salvador 3
UA - Ucraina 3
AO - Angola 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
MA - Marocco 2
PK - Pakistan 2
RO - Romania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
CH - Svizzera 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 4.024
Salva come PNG Salva come JPEG
Città #
Singapore 293
Ashburn 167
Hefei 126
Ho Chi Minh City 111
Bologna 109
San Jose 98
Hanoi 95
Hong Kong 93
Chandler 80
Santa Clara 67
Seoul 57
Milan 55
Rome 38
Dong Ket 37
Beijing 36
Council Bluffs 36
Southend 35
Los Angeles 32
Helsinki 30
Dublin 26
Fairfield 26
Princeton 26
Boardman 24
Chicago 24
Lauterbourg 22
Tokyo 21
Abidjan 20
New York 20
Frankfurt am Main 19
Seattle 19
Bengaluru 15
Catania 15
Da Nang 15
Haiphong 15
Amman 14
Buffalo 14
Lomé 14
The Dalles 14
Verona 14
Berlin 13
Bremen 13
Dallas 13
Houston 13
São Paulo 13
Abeokuta 12
Florence 11
Lappeenranta 11
Modena 10
Warsaw 10
Wilmington 10
Bến Tre 9
Cambridge 9
London 9
Guangzhou 8
Turin 8
Woodbridge 8
Brooklyn 7
Des Moines 7
Falkenstein 7
Nuremberg 7
Parma 7
Rimini 7
Atlanta 6
Brussels 6
Ottawa 6
Adelaide 5
Amsterdam 5
Baghdad 5
Biên Hòa 5
Bắc Ninh 5
Denver 5
Johannesburg 5
Mexico City 5
Novara 5
Redmond 5
Reggio Emilia 5
San Diego 5
Shenzhen 5
Tongling 5
Bangkok 4
Belgrade 4
Changsha 4
Cinisello Balsamo 4
Hyderabad 4
Hưng Yên 4
Jakarta 4
Medford 4
Nanjing 4
Nova Milanese 4
Nuoro 4
Orem 4
Shijiazhuang 4
Toronto 4
Vũng Tàu 4
Aversa 3
Bergamo 3
Birmingham 3
Boston 3
Brescia 3
Buenos Aires 3
Totale 2.360
Salva come PNG Salva come JPEG
Nome #
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 488
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 357
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 234
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 226
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 225
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 196
Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact 195
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study 193
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 186
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy 174
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 171
Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion 170
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 161
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 156
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice 146
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210 141
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia 134
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series 129
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy 125
Neuroblastoma in Neonates 112
Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma 111
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report 83
Totale 4.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022215 0 0 0 23 17 12 4 21 10 32 66 30
2022/2023356 26 49 24 50 39 17 6 32 61 10 21 21
2023/2024176 10 23 16 14 15 8 4 11 10 29 10 26
2024/20251.062 51 77 99 51 110 83 94 59 46 122 77 193
2025/20261.846 208 212 147 155 136 93 216 57 326 111 73 112
2026/2027246 45 72 115 14 0 0 0 0 0 0 0 0
Totale 4.113